Problemy perinatologii – terapia progesteronem w ciąży: fakty i mity Artykuł przeglądowy
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
gru 31, 2016
Słowa kluczowe:
skrócenie szyjki macicy, poród przedwczesny, terapia progesteronem
##plugins.themes.bootstrap3.article.main##
Abstrakt
Przedwczesne urodzenie dziecka w dalszym ciągu stanowi olbrzymie wyzwanie dla lekarzy specjalistów z dziedziny medycyny matczyno-płodowej. Suplementacja progesteronem w ciąży ogranicza niebezpieczeństwo porodu przedwczesnego u kobiet z grupy wysokiego ryzyka perinatologicznego. Rekomendacje towarzystw naukowych/perinatologicznych wskazują na istotną rolę terapii progesteronem w zapobieganiu powikłaniu ciąży, jakim jest poród przedwczesny.
##plugins.themes.bootstrap3.article.details##
Jak cytować
Tomaszewski, J. (2016). Problemy perinatologii – terapia progesteronem w ciąży: fakty i mity . Medycyna Faktów , 9(4(33), 315-319. Pobrano z https://journalsmededu.pl/index.php/jebm/article/view/2205
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Ahn K.H., Bae N.Y., Hong S.C. et al.: The safety of progestogen in the prevention of preterm birth: meta-analysis on neonatal mortality. J. Perinat. Med. 2016 [doi: 10.1515/jpm-2015-0317].
2. Norwitz E.R., Caughey A.B.: Progesterone supplementation and the prevention of preterm birth. Rev. Obstet. Gynecol. 2011; 4: 60-72.
3. da Fonseca E.B., Bittar R.E., Carvalho M.H. et al.: Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneus preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. AJOG 2003; 188: 419-424.
4. Norman J.E., Marlow N., Messow C.M. et al.; OPPTIMUM study group: Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial. Lancet 2016; 387(10033): 2106-2116.
5. Romero R., Nicolaides K.H., Conde-Agudelo A. et al.: Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Ultrasound Obstet. Gynecol. 2016; 48(3): 308-317.
6. van Os M.A., van der Ven A.J., Kleinrouweler C.E. et al.: Preventing Preterm Birth with Progesterone in Women with a Short Cervical Length from a Low-Risk Population: A Multicenter Double-Blind Placebo-Controlled Randomized Trial. Am. J. Perinatol. 2015; 32(10): 993-1000.
7. McNamara H.C., Wood R., Chalmers J. et al.; STOPPIT Baby Follow-up Study: The effect of prophylactic progesterone in twin pregnancy on childhood outcome. PLoS One. 2015; 10(4): e0122341.
8. Schuit E., Stock S., Rode L. et al; Global Obstetrics Network (GONet) collaboration: Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis. BJOG 2015; 122(1): 27-37.
9. O’Brien J.M.: Medication safety is still an issue in obstetrics 50 years after the Kefauver-Harris amendments: the case of progestogens. Ultrasound. Obstet. Gynecol. 2013; 42: 247-253.
2. Norwitz E.R., Caughey A.B.: Progesterone supplementation and the prevention of preterm birth. Rev. Obstet. Gynecol. 2011; 4: 60-72.
3. da Fonseca E.B., Bittar R.E., Carvalho M.H. et al.: Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneus preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. AJOG 2003; 188: 419-424.
4. Norman J.E., Marlow N., Messow C.M. et al.; OPPTIMUM study group: Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial. Lancet 2016; 387(10033): 2106-2116.
5. Romero R., Nicolaides K.H., Conde-Agudelo A. et al.: Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Ultrasound Obstet. Gynecol. 2016; 48(3): 308-317.
6. van Os M.A., van der Ven A.J., Kleinrouweler C.E. et al.: Preventing Preterm Birth with Progesterone in Women with a Short Cervical Length from a Low-Risk Population: A Multicenter Double-Blind Placebo-Controlled Randomized Trial. Am. J. Perinatol. 2015; 32(10): 993-1000.
7. McNamara H.C., Wood R., Chalmers J. et al.; STOPPIT Baby Follow-up Study: The effect of prophylactic progesterone in twin pregnancy on childhood outcome. PLoS One. 2015; 10(4): e0122341.
8. Schuit E., Stock S., Rode L. et al; Global Obstetrics Network (GONet) collaboration: Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis. BJOG 2015; 122(1): 27-37.
9. O’Brien J.M.: Medication safety is still an issue in obstetrics 50 years after the Kefauver-Harris amendments: the case of progestogens. Ultrasound. Obstet. Gynecol. 2013; 42: 247-253.